Liberty One Investment Management LLC trimmed its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 0.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 275,611 shares of the company's stock after selling 2,464 shares during the period. Cardinal Health comprises 3.5% of Liberty One Investment Management LLC's holdings, making the stock its biggest holding. Liberty One Investment Management LLC owned about 0.11% of Cardinal Health worth $32,596,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also modified their holdings of CAH. Paragon Capital Management Inc. lifted its position in Cardinal Health by 0.7% during the second quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company's stock valued at $1,451,000 after acquiring an additional 99 shares during the last quarter. Huntington National Bank lifted its holdings in shares of Cardinal Health by 0.9% during the 3rd quarter. Huntington National Bank now owns 10,792 shares of the company's stock valued at $1,193,000 after purchasing an additional 100 shares during the last quarter. Blair William & Co. IL boosted its position in shares of Cardinal Health by 0.9% in the 2nd quarter. Blair William & Co. IL now owns 11,442 shares of the company's stock worth $1,125,000 after purchasing an additional 103 shares in the last quarter. Frazier Financial Advisors LLC grew its stake in Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock worth $28,000 after buying an additional 104 shares during the last quarter. Finally, UMB Bank n.a. increased its position in Cardinal Health by 4.9% during the 3rd quarter. UMB Bank n.a. now owns 2,249 shares of the company's stock valued at $249,000 after buying an additional 106 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.
Cardinal Health Trading Down 0.6 %
Shares of Cardinal Health stock traded down $0.76 during trading hours on Friday, reaching $126.27. The stock had a trading volume of 1,642,944 shares, compared to its average volume of 1,877,583. The stock's 50 day moving average is $120.75 and its 200 day moving average is $111.92. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $127.27. The firm has a market capitalization of $30.56 billion, a PE ratio of 24.57, a PEG ratio of 1.48 and a beta of 0.63.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.62 by $0.26. The company had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. Cardinal Health's quarterly revenue was down 4.3% compared to the same quarter last year. During the same period last year, the company earned $1.73 earnings per share. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.82 earnings per share for the current year.
Cardinal Health Cuts Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.60%. The ex-dividend date of this dividend was Thursday, January 2nd. Cardinal Health's payout ratio is 39.30%.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on CAH. Morgan Stanley upped their price objective on shares of Cardinal Health from $127.00 to $136.00 and gave the company an "overweight" rating in a report on Tuesday, December 17th. Barclays raised their price target on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a report on Monday, November 4th. TD Cowen raised shares of Cardinal Health from a "hold" rating to a "buy" rating and boosted their price objective for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Evercore ISI raised Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price target for the company in a research report on Tuesday, January 7th. Finally, UBS Group increased their price objective on Cardinal Health from $134.00 to $139.00 and gave the company a "buy" rating in a report on Monday, November 4th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $133.29.
Get Our Latest Analysis on CAH
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.